valproic acid has been researched along with pyrimidin-2-one beta-ribofuranoside in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Corey, DR; Sakurai, F; Yu, D | 1 |
| Fu, L; Wang, XX | 1 |
| Behjoo, H; Kavoosi, F; Sanaei, M | 1 |
1 review(s) available for valproic acid and pyrimidin-2-one beta-ribofuranoside
| Article | Year |
|---|---|
[Recent advances in DNA demethylation in tumor therapy].
Topics: Animals; Cytidine; DNA Methylation; DNA Modification Methylases; Gene Knockout Techniques; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Neoplasms; RNA Interference; Valproic Acid | 2009 |
2 other study(ies) available for valproic acid and pyrimidin-2-one beta-ribofuranoside
| Article | Year |
|---|---|
Clonal Rett Syndrome cell lines to test compounds for activation of wild-type MeCP2 expression.
Topics: Clone Cells; Epigenesis, Genetic; Fibroblasts; Gene Expression Profiling; Humans; Methyl-CpG-Binding Protein 2; Molecular Structure; Mutation; Organic Chemicals; Polymerase Chain Reaction; Rett Syndrome; RNA, Messenger; Stereoisomerism | 2011 |
Effect of valproic acid and zebularine on SOCS-1 and SOCS-3 gene expression in colon carcinoma SW48 cell line.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Colonic Neoplasms; Cytidine; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling 3 Protein; Valproic Acid | 2020 |